Trientine Tetrahydrochloride (TETA 4HCL) for the Treatment of Wilson's Disease

NCT03539952 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

77

Enrollment

INDUSTRY

Sponsor class

Conditions

Wilson Disease

Interventions

DRUG: Penicillamine (D1-W12)
DRUG: TETA 4HCL (W12-60)
DRUG: Penicillamine (W12-W60)
DRUG: TETA 4HCL (60-<W108)

Sponsor

Orphalan